Avastin fakes in China were not contaminated, investigation continues

It turns out the counterfeit Avastin given off-label to Chinese patients was not contaminated as originally believed. Roche and health authorities found no microbial contamination in the fakes or the active ingredient. Researchers are now seeking a noninfectious cause for the inflammation. The 11 people who pleaded guilty in the counterfeiting case were awaiting sentencing as of May. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.